VITAMIN D STATUS OF CHILDREN WITH RECURRENT INFECTIONS AND ASTHMA
- Authors: Bugaenko E.G.1, Potapova N.L.2, Gaymolenko I.N.2, Vlasova A.N.2
-
Affiliations:
- OOO “EtalonMed”
- Chita State Medical Academy
- Issue: Vol 22, No 4 (2019)
- Pages: 1435-1437
- Section: ORIGINAL ARTICLES
- URL: https://ogarev-online.ru/1028-7221/article/view/119474
- DOI: https://doi.org/10.31857/S102872210007049-8
- ID: 119474
Cite item
Full Text
Abstract
The level of 25(OH) hydroxycholecalciferol in healthy children with recurrent respiratory diseases and patients with mild bronchial asthma was studied. It was found that in children with repeated respiratory infections there was a significant decrease in the concentration of vitamin D against the background of an increase in total serum immunoglobulin E in comparison with a group of healthy individuals. Patients with bronchial asthma of mild severity demonstrate lower values of vitamin D.
About the authors
E. G. Bugaenko
OOO “EtalonMed”
Author for correspondence.
pediatrician,
Chita
Russian FederationN. L. Potapova
Chita State Medical Academy
Email: nataliapotap@yandex.ru
PhD, Head of the Department of Outpatient Pediatrics with a course of medical rehabilitation,
Chita
Russian FederationI. N. Gaymolenko
Chita State Medical Academy
Dr. Sc., professor, Head of the Department of Pediatrics,
Chita
Russian FederationA. N. Vlasova
Chita State Medical Academy
assistant of the Department of Outpatient Pediatrics with a course of medical rehabilitation,
Chita
Russian FederationReferences
- Древаль А. В., Крюкова И. В., Барсуков И. А. и соавт. Внекостные эффекты витамина Д (обзор литературы). Русский медицинский журнал 2017; 1:53–56.
- Peçanha M. B., Freitas R. B., Moreira T. R., Silva L. S., Oliveira L. L., Cardoso S. A. Prevalence of vitamin D deficiency and its relationship with factors associated with recurrent wheezing. J Bras Pneumol. 2019 Feb 11;45(1): e20170431.
- Hejazi M.E., Modarresi-Ghazani F., Entezari-Maleki T. A review of Vitamin D effects on common respiratory diseases: Asthma, chronic obstructive pulmonary disease, and tuberculosis. J Res Pharm Pract. 2016 JanMar; 5(1): 7–15.
Supplementary files
